EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

This month, the Joe Biden administration awarded $14 million to the API Innovation Center, a Saint Louis–based nonprofit that aims to remedy supply chain problems for active pharmaceutical ingredients ...

LUXEMBOURG--(BUSINESS WIRE)--Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, ...

25% of Americans (70 million people) admitted they use illicit drugs, according to the most recent National Survey on Drug Use. 48.7 million people nationwide struggle with substance abuse according ...

MISSISSAUGA, Canada--(BUSINESS WIRE)--Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased ...

Alcami's new sterile fill-finish line supports vial formats from 2R to 30R, enhancing clinical and commercial manufacturing capabilities. Cambrex's $120 million investment will increase its Charles ...

Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under ...